TIMOTHY KAATMAN: Open Payments
NPI 1447613724 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 29 payments from 10 companies in 2025. Trend: 2023 $657 · 2024 $791 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $302 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Tris Pharma Inc | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Corium, LLC | 3 | $13 |
| TMS NeuroHealth Centers Inc. | 1 | $8 |
Products named: VRAYLAR, Auvelity, SPRAVATO, INGREZZA, Dyanavel XR, REXULTI, Qelbree, CAPLYTA.
Industry payments across IL — which companies pay providers there.
